EUROGIN 2022 Abstract Topics

1. HPV disease and COVID-19
2. Viral and molecular biology
3. Epidemiology and natural history
4. Pathogenesis
5. Immunology
6. HPV prophylactic vaccines
7. HPV therapeutic vaccines
8. Immunotherapy - Immuno-oncology - New treatments
9. HPV testing
10. HPV screening
11. Screening for women difficult to reach
12. Triage of HPV positive women
13. Self-sampling
14. Genotyping
15. Molecular markers
16. Screening methods
17. Automation in cytology
18. Methylation
19. Microbiome
20. Serology
21. New technologies
22. Artificial Intelligence
23. Diagnostic procedures / management
24. Risk management
25. Colposcopy
26. Cervical neoplasia
27. Vulvar and vaginal diseases and neoplasia
28. Anal neoplasia
29. Oral HPV infection
30. HPV and oropharynx / Head and neck cancer
31. HPV and associated skin diseases
32. Genital warts
33. HPV transmission
34. Sexually transmitted diseases and HIV infection
35. Conventional therapies
36. Economics and modelling
37. Advocacy, acceptability and psychology
38. Health education
39. Low resource settings
40. Public health
41. Fertility and HPV